A bipartisan group of lawmakers want Health Secretary Robert F. Kennedy Jr. to fill panel vacancies that enable approval of research funding, according to a letter obtained by Bloomberg Government.
Medical marijuana treatments can’t be reimbursed under federal workers’ compensation laws, a federal appeals court ruled Thursday.
Senators on both sides of the aisle scrutinized the use of artificial intelligence in patients’ health records during a hearing with a top Trump administration health information technology official Thursday.
UniQure NV’s gene therapy for Huntington’s disease is a failed product, a senior US Food and Drug Administration official said Thursday, dimming the company’s hopes that it can persuade the agency to reconsider its demand for a rigorous new clinical trial.
Immigration and Customs Enforcement must let attorneys representing noncitizens detained in Manhattan’s immigration courthouse take photos of the facilities and talk to detainees, a judge ordered Friday.
The head of the US Food and Drug Administration’s division of vaccines and gene therapies is leaving the agency after a tumultuous tenure, sending biotech shares higher in late trading on Friday.
Boston Scientific Corp. artificially inflated its stock price by touting growth in key product segments that it knew was unsustainable, leading to a disappointing revenue report and a significant stock drop, an investor alleges.
Anoxia Medical Inc. and Alembic LLC, both of which make medical catheters, have agreed to stop their patent infringement court fight as they attempt to finalize a settlement in the case.
Cellular Connection LLC, which sells
Inspired Healthcare Capital Holdings should be denied a request to fund its bankruptcy with a $35 million loan because the terms would encumber solvent senior living community projects, a group of project investors said.
Verrica Pharmaceuticals Inc. investors can proceed as a class in their suit over allegedly concealed ongoing drug production problems that delayed FDA approval, a federal court ruled.
Becton Dickinson & Co. and C.R. Bard Inc. largely lost their bid for summary judgment in a bellwether plaintiff’s suit alleging the companies’ implanted port catheters were defective and led to medical complications.
OpenAI is introducing an AI agent that’s meant to help security teams find and patch vulnerabilities in large databases, potentially cutting into demand for legacy cyber firms.
Components listed separately in patent claims must be different physical parts of a device—not one doing double duty—the Federal Circuit said in upholding a decision overturning a jury verdict that Kurin Inc. infringed a Magnolia Medical Technologies Inc. blood-testing device patent.
When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.
Immigration and Customs Enforcement must let attorneys representing noncitizens detained in Manhattan’s immigration courthouse take photos of the facilities and talk to detainees, a judge ordered Friday.
An assistant US attorney in North Carolina filed a response with the court that included “fabricated quotations and misstatements of case holdings” and then made “false or misleading statements” of how they got included, a magistrate judge said.
The Florida Bar said it mistakenly wrote in a letter last month that it was investigating former Virginia US Attorney Lindsey Halligan.
Legal tech firm Upsolve Inc. lost its fight against New York Attorney General Letitia James arguing the state’s rules against the unauthorized practice of law violated its First Amendment rights.
ModivCare asked a court to reject White & Case LLP’s $14 million final fee request for its work in the medical transportation company’s bankruptcy, accusing the law firm of deliberately burying the company’s estate in legal fees.
Dealmakers are, for the second year in a row, seeing their chances of a record haul of mergers and acquisitions potentially fizzle out before the end of the first quarter.
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas:
